Cargando…
Quality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service – results from the prospective, multi-center, observational cohort study thrombEVAL
BACKGROUND: The majority of studies on quality of oral anticoagulation (OAC) therapy with vitamin K-antagonists are performed with short-acting warfarin. Data on long-acting phenprocoumon, which is frequently used in Europe for OAC therapy and is considered to enable more stable therapy adjustment,...
Autores principales: | Prochaska, Jürgen H, Göbel, Sebastian, Keller, Karsten, Coldewey, Meike, Ullmann, Alexander, Lamparter, Heidrun, Jünger, Claus, Al-Bayati, Zaid, Baer, Christina, Walter, Ulrich, Bickel, Christoph, ten Cate, Hugo, Münzel, Thomas, Wild, Philipp S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333875/ https://www.ncbi.nlm.nih.gov/pubmed/25616558 http://dx.doi.org/10.1186/s12916-015-0268-9 |
Ejemplares similares
-
Telemedicine-Based Specialized Care Improves the Outcome of Anticoagulated Individuals with Venous Thromboembolism—Results from the thrombEVAL Study
por: Keller, Karsten, et al.
Publicado: (2020) -
Cost saving analysis of specialized, eHealth-based management of patients receiving oral anticoagulation therapy: Results from the thrombEVAL study
por: Eggebrecht, Lisa, et al.
Publicado: (2021) -
Atherosclerosis and Its Impact on the Outcomes of Patients with Deep Venous Thrombosis
por: Keller, Karsten, et al.
Publicado: (2022) -
Prediction of phenprocoumon maintenance dose and phenprocoumon plasma concentration by genetic and non-genetic parameters
por: Geisen, Christof, et al.
Publicado: (2010) -
Drug interaction: Omeprazole and Phenprocoumon
por: Enderle, Christa, et al.
Publicado: (2001)